The FDA wants to hear from you.

Join leaders from the U.S. Food and Drug Administration(FDA) for an interactive conversation about living with gynecologic cancer. Share your experiences with diagnosis, biomarker and genetic testing, treatment decisions, side effects, quality of life, and the challenges you've faced along the way. This special session is an opportunity to ask questions about the FDA's role in drug development and approval, learn how patient perspectives inform decision-making, and help shape the future of gynecologic cancer care. The panel will answer questions submitted in advance as well as live questions from attendees. Your voice matters—we hope you'll join us for this meaningful conversation.